Corlux: Clinical Trials

6 trials of Corlux, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 terminated. 3 Phase 3, 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 12Completed 2
Phase 21Terminated 1

Follow Corlux: new trials by email Literature Review of Corlux trials Research Report on Corlux

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Mifepristone - Non-Small Cell Lung Cancer (NSCLC)
Phase 2TerminatedCheck, Jerome H., M.D., Ph.D.32015-12-012020-10-19
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Mifepristone - Cushing's Disease, Cushing's Syndrome
Phase 3CompletedCorcept Therapeutics42010-11-012014-03-18
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
mifepristone - Cushing's Syndrome
Phase 3CompletedCorcept Therapeutics302009-07-012014-04-02
A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
Risperidone, Mifepristone, Risperidone-matched placebo - Healthy
Phase 1CompletedCorcept Therapeutics762008-11-012022-02-08
A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers
mifepristone + fluvastatin - Healthy Subjects
Phase 1CompletedCorcept Therapeutics202008-09-012012-02-17
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
mifepristone - Cushing's Syndrome
Phase 3CompletedCorcept Therapeutics502007-12-012013-08-22

Conditions studied

ACTH Syndrome, Ectopic (3)  ·  Cushing Syndrome (3)  ·  Pituitary ACTH Hypersecretion (3)  ·  Pituitary Diseases (3)  ·  Adrenal Cortex Neoplasms (2)  ·  Choristoma (2)  ·  Hirsutism (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Weight Gain (1)  ·  Weight Loss (1)

Sponsors

Corcept Therapeutics (5)  ·  Check, Jerome H., M.D., Ph.D. (1)

Countries

United States (5)  ·  India (1)

Top investigators

Coleman Gross, MD (2)  ·  Coleman Gross (1)  ·  Coleman Gross, M.D. (1)  ·  Dennis Swearingen, MD (1)  ·  Jerome H Check, MD,PhD (1)  ·  Thaddeus Block, MD (1)

Results publications

PMID 25013998, PMID 26507877, PMID 22466348, PMID 23970725